Short-chain fatty acids in the context of Parkinson’s disease
Main Authors: | Judith Metzdorf, Lars Tönges |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=10;spage=2015;epage=2016;aulast=Metzdorf |
Similar Items
-
Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
by: Friederike Ostendorf, et al.
Published: (2020-05-01) -
Emerging Immunotherapies for Parkinson Disease
by: Samis M. A. Zella, et al.
Published: (2018-12-01) -
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
by: Velma T. E. Aho, et al.
Published: (2021-02-01) -
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01) -
Short-chain fatty acids in diseases
by: Dan Zhang, et al.
Published: (2023-08-01)